Author Biography |
|
ix | |
Preface |
|
xi | |
Acknowledgments |
|
xv | |
1 Levels and Explanations |
|
1 | (8) |
|
Levels and Scientific Disciplines |
|
|
1 | (1) |
|
|
2 | (1) |
|
Properties and Connections |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
6 | (1) |
|
Expertise and Applications |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
2 Genes |
|
9 | (10) |
|
|
9 | (3) |
|
Gene Names and Gene Functions |
|
|
12 | (2) |
|
|
14 | (2) |
|
|
16 | (1) |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
3 Gene Expression |
|
19 | (12) |
|
Inside and Outside the Nucleus |
|
|
19 | (2) |
|
|
21 | (1) |
|
Suppression of Gene Expression |
|
|
22 | (1) |
|
Early Experience and Lasting Changes |
|
|
23 | (1) |
|
|
24 | (1) |
|
Transgenerational Effects of Environment |
|
|
25 | (1) |
|
Genes, Environment, Other |
|
|
25 | (2) |
|
|
27 | (1) |
|
A Gut Feeling About Heredity |
|
|
27 | (1) |
|
Definitions Used in This Book |
|
|
28 | (1) |
|
|
28 | (1) |
|
|
29 | (2) |
4 The Nervous System |
|
31 | (20) |
|
|
31 | (1) |
|
|
32 | (2) |
|
|
34 | (1) |
|
|
35 | (1) |
|
|
36 | (3) |
|
|
39 | (1) |
|
|
40 | (6) |
|
|
46 | (2) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (2) |
5 Development |
|
51 | (16) |
|
|
51 | (2) |
|
Emergence of the Nervous System |
|
|
53 | (6) |
|
|
59 | (2) |
|
Plasticity of Development |
|
|
61 | (2) |
|
|
63 | (1) |
|
|
64 | (3) |
6 Behavior |
|
67 | (16) |
|
Kinds of Tests and Measures |
|
|
67 | (4) |
|
Behaviors Vs Psychological Constructs |
|
|
71 | (1) |
|
Goals of Testing and Applications of Test Scores |
|
|
72 | (1) |
|
Standardized Psychological Tests |
|
|
72 | (2) |
|
|
74 | (2) |
|
|
76 | (1) |
|
Clinical Interview and Diagnosis |
|
|
77 | (3) |
|
|
80 | (1) |
|
|
80 | (1) |
|
|
81 | (2) |
7 Single-Gene and Chromosomal Disorders |
|
83 | (8) |
|
|
83 | (2) |
|
|
85 | (2) |
|
The Relation of Genotype to Phenotype: Gene Expression |
|
|
87 | (1) |
|
Multiple Alleles, Genotypes, and Phenotypes |
|
|
87 | (2) |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
90 | (1) |
8 Phenylketonuria (PKU) |
|
91 | (14) |
|
Transmission and Frequency |
|
|
92 | (1) |
|
Chemical Pathway and Prevention |
|
|
93 | (1) |
|
Newborn Screening, Prevention and a Critical Period |
|
|
94 | (1) |
|
|
95 | (1) |
|
Other Causes of Elevated Phenylalanine |
|
|
95 | (1) |
|
|
96 | (1) |
|
|
96 | (1) |
|
Social Factors and Compliance |
|
|
97 | (1) |
|
Lessons Learned 30 Years Ago |
|
|
97 | (1) |
|
|
98 | (1) |
|
|
98 | (2) |
|
|
100 | (2) |
|
|
102 | (1) |
|
|
103 | (2) |
9 Huntington Disease |
|
105 | (10) |
|
|
105 | (1) |
|
|
106 | (1) |
|
Mutant Genotype, Normal Phenotype |
|
|
107 | (1) |
|
|
108 | (1) |
|
The Function of Huntingtin Protein |
|
|
108 | (1) |
|
|
108 | (3) |
|
|
111 | (1) |
|
Prevention of HD in Current Generation |
|
|
111 | (1) |
|
Prevention of HD in Future Generations |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
114 | (1) |
10 Androgen Insensitivity Syndrome (AIS) |
|
115 | (14) |
|
|
115 | (1) |
|
Modes of Transmission and Expression |
|
|
115 | (1) |
|
Hormone Synthesis and Receptors |
|
|
116 | (1) |
|
AR Gene Structure and Function |
|
|
116 | (2) |
|
|
118 | (1) |
|
Phenotypes and Genotypes in AIS |
|
|
119 | (1) |
|
|
120 | (1) |
|
Gene Expression and Function |
|
|
120 | (1) |
|
Sex Differences in Gene Expression |
|
|
121 | (1) |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
Terminology, Respect and Human Rights |
|
|
124 | (2) |
|
|
126 | (1) |
|
|
126 | (3) |
11 Leber's Optic Neuropathy |
|
129 | (8) |
|
The Puzzle Solved: Mitochondria |
|
|
130 | (1) |
|
Incomplete Penetrance, Sex, Smoking, Recovery |
|
|
131 | (1) |
|
Prevalence and Founder Effects |
|
|
132 | (1) |
|
|
132 | (2) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
135 | (1) |
|
|
136 | (1) |
12 Down Syndrome |
|
137 | (12) |
|
|
137 | (1) |
|
Terminology-The Demise of "Mongolism" |
|
|
137 | (1) |
|
|
138 | (1) |
|
|
139 | (1) |
|
Maternal Age and Parental Origin of the Extra Chromosome |
|
|
139 | (1) |
|
Screening for Down Syndrome |
|
|
140 | (1) |
|
|
141 | (1) |
|
Genes in the DS Critical Region |
|
|
141 | (3) |
|
Mouse Models to the Rescue? |
|
|
144 | (1) |
|
|
144 | (1) |
|
The Continuing Quest for a Cure |
|
|
145 | (1) |
|
|
146 | (1) |
|
|
146 | (3) |
13 The XYY Male |
|
149 | (10) |
|
|
150 | (1) |
|
Frequencies of XYY in Large Surveys |
|
|
150 | (1) |
|
New Research Ethics and Old Myths |
|
|
151 | (1) |
|
|
152 | (1) |
|
Mortality and Termination |
|
|
152 | (1) |
|
|
153 | (1) |
|
The Case of Mario: Imputable and Dangerous? |
|
|
153 | (1) |
|
|
154 | (2) |
|
Other Chromosome Anomalies |
|
|
156 | (1) |
|
|
156 | (1) |
|
|
157 | (2) |
14 Complex Traits |
|
159 | (14) |
|
Two Approaches to Understanding Heredity |
|
|
160 | (1) |
|
Finding Genes and Mutations |
|
|
161 | (3) |
|
|
164 | (3) |
|
|
167 | (3) |
|
|
170 | (1) |
|
|
171 | (1) |
|
|
172 | (1) |
15 Intelligence |
|
173 | (24) |
|
The Rise of Intelligence Testing |
|
|
173 | (4) |
|
|
177 | (1) |
|
|
177 | (4) |
|
|
181 | (5) |
|
Statistical Interlude: Inferential Statistics |
|
|
186 | (1) |
|
|
187 | (4) |
|
|
191 | (2) |
|
|
193 | (1) |
|
|
193 | (2) |
|
|
195 | (2) |
16 Autism |
|
197 | (14) |
|
|
197 | (3) |
|
|
200 | (2) |
|
|
202 | (1) |
|
|
203 | (4) |
|
Reducing the Prevalence of Autism |
|
|
207 | (1) |
|
|
208 | (1) |
|
|
209 | (1) |
|
|
210 | (1) |
17 Schizophrenia |
|
211 | (24) |
|
|
211 | (1) |
|
|
212 | (1) |
|
|
212 | (1) |
|
Research Domain Criteria (RDoC) |
|
|
213 | (1) |
|
|
214 | (3) |
|
|
217 | (1) |
|
|
218 | (4) |
|
|
222 | (6) |
|
|
228 | (2) |
|
|
230 | (1) |
|
|
231 | (4) |
18 Sexuality and Gender |
|
235 | (16) |
|
|
235 | (3) |
|
|
238 | (1) |
|
|
239 | (1) |
|
|
240 | (5) |
|
|
245 | (2) |
|
Another Look at "Born This Way" |
|
|
247 | (2) |
|
|
249 | (1) |
|
|
249 | (2) |
19 Race |
|
251 | (18) |
|
A Brief History of Humanity |
|
|
251 | (6) |
|
|
257 | (3) |
|
|
260 | (4) |
|
|
264 | (1) |
|
|
265 | (1) |
|
|
266 | (1) |
|
|
267 | (2) |
20 The Future |
|
269 | (10) |
|
|
269 | (1) |
|
Anticipating Future Trends |
|
|
270 | (2) |
|
|
272 | (1) |
|
Cystic Fibrosis Dizzying Complexity and Cost |
|
|
272 | (1) |
|
|
273 | (1) |
|
|
274 | (2) |
|
|
276 | (3) |
Index |
|
279 | |